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Abstract  
Introduction Lung cancer is highly prevalent and is the major cause of cancer-related deaths 
worldwide.  Severity of weight loss has been shown to have a negative impact on patients’ 
performance and quality of life.  Early detection of anorexia and decline of functional capacity will 
be very useful to prevent severe weight loss and for better prognosis.  This study aims to find 
relationship between nutritional status with functional capacity and appetite in lung cancer 
cachexia patients  
Methods A cross sectional study was conducted in Dharmais Cancer Hospital.  Subjects were adult 
patients over 18 years old with newly diagnosed lung cancer or a minimal of 2 months post 
chemotherapy or radiotherapy, taken consecutively from inpatients and outpatients.  Patients with 
hepatic cirrhosis and end stage kidney disease were excluded.  Parameters of functional capacity 
(ECOG) and appetite (VAS and SNAQ) were the dependent variables, while nutritional status were 
the independent.  
Results Subjects eligible for the study were 47 patients: 55.3% men and 44.7% women with the age 
range from 36–79 years old. There were significant relationship between body weight and BMI with 
ECOG score (p=0.038; p=0.016). Body weight, BMI and weight loss related significantly with VAS 
appetite (p=0.016; p=0.006; p=0.028) and SNAQ score (p=0.005; p=0.009; p=0.028; p=0.014).  These 
result indicate that subjects with a higher BMI and a lower weight loss have a better physical 
performance and appetite.  There were significant relation between hemoglobin level, anemia 
status and serum albumin level with VAS appetite (p=0.004; p=0.004; p=0031) and risk for anorexia 
(p=0.038; p=0.004). This result indicate that subjects with normal hemoglobin and albumin have 
good appetite and lower risk for anorexia. 
Conclusion higher nutritional status, including body weight, BMI, hemoglobin and albumin 
positively affect functional capacity and appetite. 
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Introduction 
 
The incidence of cancer is increasing worldwide and 
with it the prevalence of malnutrition, which may 
vary between 40 and 80%.  The etiology of 
malnutrition in cancer patients is complex, 
multifactorial and may be influenced by the location 
and type of tumor, stage of the disease, side effects 
of the treatment, socioeconomic status, functional 
performance, symptoms of nutritional impact, need 
for fasting and inadequate nutritional therapy, as 
well as medical staff awareness about the 
importance of nutritional status for the prognosis 
and quality of life of hospitalized patients.1,2  Weight 
loss is the primary defining feature of the wasting 
syndrome, cancer cachexia.3 Cachexia is a condition 
where skeletal muscle mass and adipose tissue are 
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progressively wasted. Incidence of cancer cachexia 
in patients with a cancer is more than 50%.  The 
presence of some degree of weight loss in 60% of 
some gastrointestinal tumors and 80% of lung 
cancers upon diagnosis suggest that cancer cachexia 
should be considered as an “early event”.  Lung 
cancer is highly prevalent and the major cause of 
cancer-related deaths worldwide. Severity of weight 
loss has been shown to have a negative impact on 
patients’ performance and quality of life.4,5   
The prominent clinical feature of cachexia is 
weight loss, anorexia, inflammation, insulin 
resistance, and increased muscle protein 
breakdown.6  Patients with cancer cachexia 
frequently report reduced appetite and have reduced 
food intake. Paradoxically, it is still unclear what 
proportion of cancer related weight loss can be 
attributed to reduced dietary intake and how much 
cancer-related weight loss could be prevented or 
reversed by increasing nutritional intake.7  Normal 
appetite involves peripheral and central pathways. 
Peripheral appetite control has four phases of normal 
hunger and satiety cycles. The four phases are 
gastric motility phase, post absorptive phase, 
metabolic phase and ileal phase.  Central appetite 
control depends on the balance between energy 
inputs and resting energy expenditure governed by a 
parallel system of NPY and pro-opiomelanocortin 
(POMC).  NPY and POMC are regulated primarily 
by leptin and serotonin. NPY and agouti-gene 
related transcript (AGRP) is the main appetite 
stimulating central neurotransmitters with separate 
but synergistic appetite response. POMC reduces 
appetite by opposing the actions of NPY. Leptin is 
the dominant negative peripheral NPY regulator 
secreted by white adipocytes. Serotonin inhibits 
NPY neuron activity cause satiety.8 
Cachexia contributes substantially to 
morbidity in cancer patients. It is associated with 
symptoms such as fatigue, weakness, poor physical 
performance, and thus leads to a lower self-rated 
quality of life.  Patients who continue to lose weight 
while receiving palliative chemotherapy have 
reduced global quality of life and performance 
scores when compared to those whose weight loss 
stabilises.6 
The assessment of the body weight change, 
nutritional status, and non-obvious symptoms that 
affect nutrition tend to be relatively low on the 
priority list.9  The identification of factors that can 
be assessed during the hospital admission can alert 
the medical and healthcare staff about the need for 
evaluation and early nutritional intervention to avoid 
further complications, an increase in length of 
hospital stay and costs.10   
The above description shows that functional 
capacity and appetite are prognostic factors for 
cancer patients.  Then lead us to questions, are there 
relation between nutritional status with functional 
capacity and appetite. The aim of the study was to 
find relation between nutritional status with 
functional capacity and appetite. 
 
 
Methods 
 
A cross sectional study was conducted in Dharmais 
Cancer Hospital, as part of a larger study on the 
association between cytokines pro and anti-
inflammatory. The study was approved by the 
Committee for Ethics in Research of the Dharmais 
Cancer Hospital. Patient recruitment took place 
from September 2017 to May 2018.  Subjects were 
lung cancer patients newly diagnosed or a minimal 
of 2 months post chemotherapy or radiotherapy, 
taken consecutively from outward and inward. Sixty 
patients agree to take part of the study by signing 
written informed consent, 47 were eligible to take 
part in this study.  
 The anthropometric variables, body height 
and weight, was measured twice and then calculated 
the average  by medical doctor with SECA portable 
stadiometer and SECA body weight scale with a 
variation of 0.01 cm and 0.1 kg precision.  BMI was 
calculated as weight (kg)/height squared (m2). The 
performance status was obtained from the scale 
developed by the Eastern Cooperative Oncology 
Group (ECOG), which ranks the functional capacity 
in five levels. Level zero indicates the individual is 
fully active, and level four indicates the bedridden 
and unable to perform self care activities. Appetite 
was measured with VAS, and the risk for anorexia 
was measured using SNAQ. Serum albumin and 
hemoglobin, obtained from blood vein analysis, 
were measured as parameters of nutritional status. 
All laboratory values were determined using routine 
automated analyzers at the Department of Clinical 
Pathology of Dharmais Cancer Hospital. 
The database was structured using the 
Microsoft Excel 2013 software, and the analyses 
were done using the Statistical Package for Social 
Sciences (SPSS) software version 20 for Windows. 
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The numeric variables were described with mean 
(standard deviation) for normal distributed data or 
median (minimal–maximal) value for otherwise. 
Comparison between patient groups was assessed 
using T-test or Mann-Whitney, according to data 
distribution. The Chi Squared or Mann-Whitney U 
test were utilized to associate clinical and 
biochemical parameters, and malnutrition. 
Statistical significance was determined as p < 0.05 
with a two-sided test.  
 
Results 
 
Sixty patients agreed to take part of the study, 47 of 
them fulfilled the study subject criteria.  Subjects of 
the study composed of 55.3% men and 44.7% 
women, with the age range from 36–79 years old.  
The highest age range was between 51–65 years old 
(40.4%). 
 
Table 1. Subject characteristics 
 
Characteristics  Percentage (%) 
Sex 
     male 
     female 
 
26 
21 
 
55.3 
44.7 
Age, year   
     36 – 50 14 29.8 
     51 – 65  19 40.4 
     >65 14 29.8 
 
The median body weight was 49.2 (35 – 78) kg, with 
average BMI 20.4 ± 4.0 kg/m2.  The average weight 
loss in 6 months was 14.9 ± 7.8, while the median in 
12 months was 14.7 (0–32.6) kg. The average 
albumin level was 3.2 ± 0,6 g/dL, hypoalbuminemia 
occurred in 48.9. The average hemoglobin level was 
11.3 ± 1.7 g/dL, anemia was found in 63.8%.   
There were significant relationship between 
body weight and ECOG score, VAS appetite and 
SNAQ score.  Body mass index was significantly 
related to ECOG score. Weight loss in six months 
was related with SNAQ score, while weight loss in 
twelve months were related with VAS appetite and 
SNAQ score. There were significant relation 
between hemoglobin level and VAS appetite, and 
anemia status was related significantly with appetite 
status. This result indicates that subjects with normal 
hemoglobin have a good appetite. Anemia status 
was related significantly with anorexia risk status, 
which indicates that subjects with anemia have a 
higher risk for anorexia. We found that there were 
significant relation between albumin level and VAS 
appetite and SNAQ score (Table 2). 
 
Discussion 
 
Nutritional and functional deterioration are so 
frequently encountered in cancer patients that they 
are often accepted as part of the disease. The 
majority of patients with advanced lung cancer also 
present with malnourishment and, subsequently, 
with hypoalbuminemia and anemia.11 There were 
significant relationship between body weight and 
ECOG score, VAS appetite and SNAQ score. Body 
mass index (BMI) was significantly related to 
ECOG score.  ECOG score is the picture of one 
functional capacity, this result shows us that body 
weight and BMI significantly affected functional 
capacity. A Greek prospective study conducted with 
lung cancer showed an association between the 
performance status and the weight loss of more than 
5%  in the last 3 months, percent weight loss is as an 
indicative of a considerable deterioration of the 
nutritional status.10 
This study found that weight loss in six 
months was related with SNAQ score, while weight 
loss in twelve months was related with VAS appetite 
and SNAQ score. Nasrah et al,7 did not found a 
correlation between weight loss and appetite.  
Anorexia or loss of appetite was the symptom most 
closely linked to both reduced dietary intake and 
weight loss, as well as being an independent 
explanatory variable for weight change in 
multivariate analysis. This is consistent with the 
concept that the symptom of anorexia can promote 
weight loss through reduced food intake, but also 
that anorexia can be an indicator of cancer- related 
changes in central nervous system signaling that 
promote tissue loss independent of food intake. 
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Table 2. Nutritional status related to ECOG score, VAS appetite and SNAQ score 
 
Nutritional status ECOG score VAS appetite Risk of anorexia 
 Low 
N=21 
Good 
N=26 
p Low 
n=15 
Good 
n=32 
p Risk 
 
n=26 
Not at Risk 
n=21 
p 
Body weight, Kg 48.9±9.1 54.7±9.4 p=0.038 47.2±7.5 54.4±9.8 p=0.016 48 (35-75) 55.8±9.4 p=0.005 
Height, Kg 161.6±8.0 159.2±7.5 p=0.289 162.2±9.2 159.3±6.9 p=0.244 160.8±8.1 159.5±7.3 p=0.583 
BMI, Kg/m2 18.9±3.8 21.6±3.7 p=0.016 18.1±3.7 21.5±3.7 p=0.006 18.5(13.1-
27.1) 
22.0±3.7 p=0.009 
Weight loss:          
6 months 14.9±8.3 12.6(5,1-
32.6)* 
p=0.923 18.0±8.0 11.8(0-32.0) p=0.055 17.2±7.7 12.2±7.1 p=0.028 
12 months 16.7±9.4 15.3±7.6 p=0.588 19.8±8.8 14.1±7.7 p=0.028 18.6±8.3 12.7±7.5 p=0.014 
Hemoglobin, mg/dL 10.8±1.7 11.7±1.7 p=0.070 10.2±1.5 11.8±1.6 P=0.004 10.9±1.7 11.8±1.7 p=0.070 
Anemia 15 15 p=0.330 14 16 P=0.004 20 10 p=0.038 
Normal 6 11  1 16  6 11  
Albumin, g/dL 3.0±0.5 3.3±0.6 p=0.089 2.9±0.5 3.3±0.6 P=0.031 3.0±0.5 3.4±0.6 p=0.004 
Hypoalbuminemia 12 11 p=0.312 10 13 P=0.096 16 7 p=0.054 
Normal 9 15  5 19  10 14  
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Studies in cancer-bearing rodents have shown 
elevated levels of inflammatory cytokines in the 
hypothalamus which can induce anorexia. The 
anorexia induced by hypothalamic inflammatory 
mediators can be reversed by melanocortin type-4 
receptor blockade, but centrally acting cytokines 
such as IL-1b can also trigger muscle wasting, 
independent of central melanocortin signaling. We 
hypothesize that for some patients with cancer 
cachexia and anorexia, the presence of anorexia is a 
marker for cancer-related hypothalamic 
inflammatory cytokine signaling. If this central 
signaling also directly triggers tissue catabolism and 
weight loss in humans, its effects would likely not 
be reversed by increased nutritional intake alone. 
This in turn would explain the independent 
explanatory power of anorexia for weight change, 
even when dietary intake is taken into account.12,13,14  
There was a significant relation between 
hemoglobin level and VAS appetite, and anemia 
status was related significantly with Appetite status. 
This result indicate that subjects with normal 
hemoglobin have a good appetite. Anemia status 
was related significantly with anorexia risk status, 
this result indicate that subjects with anemia have a 
higher risk for anorexia.  Kalantar Zadeh et al, on 
their study in hemodialysis patients found a similar 
trend was also found for blood hemoglobin, patients 
with a diminished appetite had a slightly lower 
hemoglobin concentration.15  This result shows us 
that to maintain good appetite we must maintain our 
cancer patient’s hemoglobin.  We found that there 
was a significant relation between Albumin level 
and VAS appetite and SNAQ score (Table 1). 
Arrieta et all,11 found the same result: 
hypoalbuminemia was associated with loss of 
appetite in cancer patients. A need for normal 
albumin level, by this result, is needed for a good 
appetite. 
Our results in this study shows that 
maintaining body weight is very important for 
cancer patients in order to have a good physical 
performance, which will also affect their prognosis.  
This study give an evidence that cancer patients 
appetite affected by many factors.  Those factors 
were body weight, BMI, weight loss, hemoglobin 
and albumin level. 
In conclusion, this study shows that 
nutritional status, including body weight, BMI, 
hemoglobin and albumin are related with functional 
capacity and appetite. Maintaining body weight, 
BMI, normal hemoglobin and albumin are keys 
factors of functional capacity and appetite.  Serum 
Albumin and hemoglobin are simple and cheap tests, 
clinical markers that may be used to assess the risk 
of anorexia in cancer patients objectively.  Screening 
for nutritional status, including body weight, BMI, 
history of weight loss and biochemical markers are 
very important to do in cancer patients. 
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